European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.57% to 1,294.83 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and biotech firm Evaxion Biotech (EVAX), which climbed 7.3% and 6.3% respectively. They were followed by petroleum refiner Equinor (EQNR) and biopharmaceutical company Genfit (GNFT), which rose 3.7% and 2.9% respectively.

The decliners from continental Europe were led by financial services companies Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which fell 2.2% and 1.8% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and software firm SAP (SAP), which dropped 1.7% and 0.6% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN), which advanced 15%, followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which rose 13% each. They were followed by biopharmaceutical company Amarin (AMRN), which increased 9.3%.

The decliners from the UK and Ireland were led software firm by Endava (DAVA) and financial services company HSBC (HSBC), which lost 1.3% and 1% respectively. They were followed by alcoholic beverages company Diageo (DEO) and biopharmaceutical company TC Biopharm (TCBP), which were off 0.8% and 0.5% respectively.